Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Prespecified candidate biomarkers identify follicular lymphoma patients who achieved longer progression-free survival with bortezomib-rituximab versus rituximab. [electronic resource] by
- Coiffier, Bertrand
- Li, Weimin
- Henitz, Erin D
- Karkera, Jayaprakash D
- Favis, Reyna
- Gaffney, Dana
- Shapiro, Alice
- Theocharous, Panteli
- Elsayed, Yusri A
- van de Velde, Helgi
- Schaffer, Michael E
- Osmanov, Evgenii A
- Hong, Xiaonan
- Scheliga, Adriana
- Mayer, Jiri
- Offner, Fritz
- Rule, Simon
- Teixeira, Adriana
- Romejko-Jarosinska, Joanna
- de Vos, Sven
- Crump, Michael
- Shpilberg, Ofer
- Zinzani, Pier Luigi
- Cakana, Andrew
- Esseltine, Dixie-Lee
- Mulligan, George
- Ricci, Deborah
Producer: 20131112
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19
Availability: No items available.
|